activistcompany
Daniel J. Mangless nominated Board candidates to Zevra Therapeutics (ZVRA)
Key Summary: Daniel J. Mangless, who successfully elected three nominees to the Board at the 2023 AGM, filed proxy materials
We focus exclusively on U.S. and Canadian stocks under $5 billion.
Our flagship: the Idea Generation Report. Each month, we spotlight 10–15 companies with compelling change narratives, found through rigorous, qualitative work.
We also summarize key developments such as shareholder activism, divestments, exploration of strategic alternatives, notable fund letters, and significant management changes.